Curvebeam AI Ltd. ( (AU:CVB) ) has issued an update.
CurveBeam AI Limited announced that its CEO, Greg Brown, will present at the NWR Virtual Healthcare Conference, highlighting the company’s advancements in medical imaging technology. This participation underscores CurveBeam AI’s commitment to innovation in musculoskeletal condition management and its strategic positioning in the healthcare industry.
More about Curvebeam AI Ltd.
CurveBeam AI Limited operates in the medical imaging industry, developing, manufacturing, and selling specialized CT scanners and AI SaaS-based clinical assessment solutions. Their flagship product, the HiRise™ CT scanner, provides both weight-bearing and traditional CT scans, offering advantages over traditional CT or MRI devices. The company is headquartered in Melbourne, Australia, with global operations in Hatfield, Pennsylvania.
YTD Price Performance: -17.86%
Average Trading Volume: 314,638
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$44.83M
For a thorough assessment of CVB stock, go to TipRanks’ Stock Analysis page.